92 related articles for article (PubMed ID: 23422502)
1. Prevalence and incidence of comorbidities in elderly women with ovarian cancer.
Chia VM; O'Malley CD; Danese MD; Lindquist KJ; Gleeson ML; Kelsh MA; Griffiths RI
Gynecol Oncol; 2013 May; 129(2):346-52. PubMed ID: 23422502
[TBL] [Abstract][Full Text] [Related]
2. Ovarian cancer: can we make the clinical diagnosis earlier?
Smith LH; Morris CR; Yasmeen S; Parikh-Patel A; Cress RD; Romano PS
Cancer; 2005 Oct; 104(7):1398-407. PubMed ID: 16116591
[TBL] [Abstract][Full Text] [Related]
3. An international assessment of ovarian cancer incidence and mortality.
Lowe KA; Chia VM; Taylor A; O'Malley C; Kelsh M; Mohamed M; Mowat FS; Goff B
Gynecol Oncol; 2013 Jul; 130(1):107-14. PubMed ID: 23558050
[TBL] [Abstract][Full Text] [Related]
4. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.
Edwards BK; Brown ML; Wingo PA; Howe HL; Ward E; Ries LA; Schrag D; Jamison PM; Jemal A; Wu XC; Friedman C; Harlan L; Warren J; Anderson RN; Pickle LW
J Natl Cancer Inst; 2005 Oct; 97(19):1407-27. PubMed ID: 16204691
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Comorbid Medical Conditions in the National Cancer Database and the SEER-Medicare Database.
Lin CC; Virgo KS; Robbins AS; Jemal A; Ward EM
Ann Surg Oncol; 2016 Dec; 23(13):4139-4148. PubMed ID: 27535406
[TBL] [Abstract][Full Text] [Related]
7. Racial and Ethnic Variability in the Prevalence and Incidence of Comorbidities Associated with Gastric Cancer in the United States.
Lowe KA; Danese MD; Gleeson ML; Langeberg WJ; Ke J; Kelsh MA
J Gastrointest Cancer; 2016 Jun; 47(2):168-81. PubMed ID: 26961791
[TBL] [Abstract][Full Text] [Related]
8. Regional variation in cancer-directed surgery and mortality among women with epithelial ovarian cancer in the Medicare population.
Fairfield KM; Lucas FL; Earle CC; Small L; Trimble EL; Warren JL
Cancer; 2010 Oct; 116(20):4840-8. PubMed ID: 20578182
[TBL] [Abstract][Full Text] [Related]
9. Comorbidity-adjusted life expectancy: a new tool to inform recommendations for optimal screening strategies.
Cho H; Klabunde CN; Yabroff KR; Wang Z; Meekins A; Lansdorp-Vogelaar I; Mariotto AB
Ann Intern Med; 2013 Nov; 159(10):667-76. PubMed ID: 24247672
[TBL] [Abstract][Full Text] [Related]
10. Symptoms, diagnoses, and time to key diagnostic procedures among older U.S. women with ovarian cancer.
Ryerson AB; Eheman C; Burton J; McCall N; Blackman D; Subramanian S; Richardson LC
Obstet Gynecol; 2007 May; 109(5):1053-61. PubMed ID: 17470582
[TBL] [Abstract][Full Text] [Related]
11. Data sources for measuring comorbidity: a comparison of hospital records and medicare claims for cancer patients.
Klabunde CN; Harlan LC; Warren JL
Med Care; 2006 Oct; 44(10):921-8. PubMed ID: 17001263
[TBL] [Abstract][Full Text] [Related]
12. A SEER-Medicare population-based study of lymphedema-related claims incidence following breast cancer in men.
Reiner AS; Jacks LM; Van Zee KJ; Panageas KS
Breast Cancer Res Treat; 2011 Nov; 130(1):301-6. PubMed ID: 21735047
[TBL] [Abstract][Full Text] [Related]
13. Ovarian cancer incidence in the United States, 1992-1999.
Quirk JT; Natarajan N
Gynecol Oncol; 2005 May; 97(2):519-23. PubMed ID: 15863154
[TBL] [Abstract][Full Text] [Related]
14. Cost of care for elderly cancer patients in the United States.
Yabroff KR; Lamont EB; Mariotto A; Warren JL; Topor M; Meekins A; Brown ML
J Natl Cancer Inst; 2008 May; 100(9):630-41. PubMed ID: 18445825
[TBL] [Abstract][Full Text] [Related]
15. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
Hershman D; Neugut AI; Jacobson JS; Wang J; Tsai WY; McBride R; Bennett CL; Grann VR
J Natl Cancer Inst; 2007 Feb; 99(3):196-205. PubMed ID: 17284714
[TBL] [Abstract][Full Text] [Related]
16. The prevalence of patients with colorectal carcinoma under care in the U.S.
Mariotto A; Warren JL; Knopf KB; Feuer EJ
Cancer; 2003 Sep; 98(6):1253-61. PubMed ID: 12973850
[TBL] [Abstract][Full Text] [Related]
17. Associations between hospital and surgeon procedure volumes and patient outcomes after ovarian cancer resection.
Schrag D; Earle C; Xu F; Panageas KS; Yabroff KR; Bristow RE; Trimble EL; Warren JL
J Natl Cancer Inst; 2006 Feb; 98(3):163-71. PubMed ID: 16449676
[TBL] [Abstract][Full Text] [Related]
18. An algorithm for the use of Medicare claims data to identify women with incident breast cancer.
Nattinger AB; Laud PW; Bajorunaite R; Sparapani RA; Freeman JL
Health Serv Res; 2004 Dec; 39(6 Pt 1):1733-49. PubMed ID: 15533184
[TBL] [Abstract][Full Text] [Related]
19. Incidence of heart failure or cardiomyopathy after adjuvant trastuzumab therapy for breast cancer.
Chen J; Long JB; Hurria A; Owusu C; Steingart RM; Gross CP
J Am Coll Cardiol; 2012 Dec; 60(24):2504-12. PubMed ID: 23158536
[TBL] [Abstract][Full Text] [Related]
20. Risk of ovarian cancer in BRCA1 and BRCA2 mutation-negative hereditary breast cancer families.
Kauff ND; Mitra N; Robson ME; Hurley KE; Chuai S; Goldfrank D; Wadsworth E; Lee J; Cigler T; Borgen PI; Norton L; Barakat RR; Offit K
J Natl Cancer Inst; 2005 Sep; 97(18):1382-4. PubMed ID: 16174860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
